{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:25:32Z","timestamp":1789881932713,"version":"4.0.1"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI079031"],"award-info":[{"award-number":["R01 AI079031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI107301"],"award-info":[{"award-number":["R01 AI107301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI117213"],"award-info":[{"award-number":["R21AI117213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K08DK101754"],"award-info":[{"award-number":["1K08DK101754"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-15-048-01-MPC"],"award-info":[{"award-number":["RSG-15-048-01-MPC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund Award","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI117213"],"award-info":[{"award-number":["R21AI117213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007273","name":"Weill Cornell Center for Advanced Digestive Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000937","name":"Alice Bohmfalk Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.coviro.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T14:21:19Z","timestamp":1470493279000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Hepatocarcinogenesis associated with hepatitis B, delta and C viruses"],"prefix":"10.1016","volume":"20","author":[{"given":"Elham","family":"Shirvani-Dastgerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ploss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.07.009_bib0675","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2016.07.009_bib0680","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2016.07.009_bib0685","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib0690","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"Buti","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2016.07.009_bib0695","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000282076","article-title":"Hepatitis delta: immunopathogenesis and clinical challenges","volume":"28","author":"Grabowski","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib0700","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1038\/emi.2014.62","article-title":"Oncogenes and RNA splicing of human tumor viruses","volume":"3","author":"Ajiro","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2016.07.009_bib0705","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.07.009_bib0710","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.chom.2014.10.009","article-title":"The impact of hepatitis C virus entry on viral tropism","volume":"16","author":"Ding","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.07.009_bib0715","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-08-2418","article-title":"Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma","volume":"15","author":"Fishman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coviro.2016.07.009_bib0720","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/514114","article-title":"Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients","volume":"176","author":"Zehender","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jmv.1095","article-title":"Study of the infection of human blood derived monocyte\/macrophages with hepatitis C virus in vitro","volume":"65","author":"Caussin-Schwemling","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0730","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1099\/vir.0.80071-0","article-title":"Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo","volume":"85","author":"Deforges","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0735","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/526519","article-title":"Molecular and bioinformatic evidence of hepatitis C virus evolution in brain","volume":"197","author":"Fishman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib0740","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0745","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib0750","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0042-6822(90)90298-6","article-title":"Replication of hepatitis B virus in transfected nonhepatic cells","volume":"179","author":"Seifer","year":"1990","journal-title":"Virology"},{"issue":"Pt 1","key":"10.1016\/j.coviro.2016.07.009_bib0755","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1099\/0022-1317-73-1-173","article-title":"Human non-hepatocytes support hepadnaviral replication and virion production","volume":"73","author":"Galun","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.07.009_sbref0760","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_sbref0765","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2016.07.009_bib0770","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jhep.2016.02.011","article-title":"Entry of hepatitis B and hepatitis D virus into hepatocytes: basic insights and clinical implications","volume":"64","author":"Li","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0775","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.coviro.2016.07.009_bib0780","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5501\/wjv.v4.i2.36","article-title":"Molecular interactions between hepatitis B virus and delta virus","volume":"4","author":"Shirvani-Dastgerdi","year":"2015","journal-title":"World J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0785","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2005.09.033","article-title":"Hepatitis delta virus","volume":"344","author":"Taylor","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.07.009_bib0790","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0042-6822(03)00209-5","article-title":"Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle","volume":"312","author":"Nguyen","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.07.009_bib0795","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3892\/or.2016.4775","article-title":"Hepatitis C virus core protein regulates OCT4 expression and promotes cell cycle progression in hepatocellular carcinoma","volume":"36","author":"Zhou","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.coviro.2016.07.009_bib0800","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/onc.2012.484","article-title":"Hepatitis C virus-induced activation of beta-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events","volume":"32","author":"Higgs","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2016.07.009_bib0805","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.canlet.2014.09.027","article-title":"Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK\/p38\/NF-kappaB signal cascade","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.coviro.2016.07.009_bib0810","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ijc.26140","article-title":"Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice","volume":"130","author":"Jeannot","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2016.07.009_bib0815","first-page":"683","article-title":"PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice","volume":"118","author":"Tanaka","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.07.009_bib0820","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1440-1746.2009.06201.x","article-title":"Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-kappaB pathway","volume":"25","author":"Li","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0825","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.M512536200","article-title":"Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1","volume":"281","author":"Spaziani","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.07.009_bib0830","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1136\/gut.2005.070417","article-title":"Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB","volume":"55","author":"Sato","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2016.07.009_bib0835","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1756-9966-32-64","article-title":"Cause-specific telomere factors deregulation in hepatocellular carcinoma","volume":"32","author":"El Idrissi","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.coviro.2016.07.009_bib0840","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4254\/wjh.v4.i12.342","article-title":"Hepatitis C virus-related hepatocellular carcinoma: an insight into molecular mechanisms and therapeutic strategies","volume":"4","author":"Selimovic","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0845","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1074\/jbc.M110.217653","article-title":"Extracellular hepatitis C virus core protein activates STAT3 in human monocytes\/macrophages\/dendritic cells via an IL-6 autocrine pathway","volume":"286","author":"Tacke","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.07.009_bib0850","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmv.21644","article-title":"Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells","volume":"82","author":"Zhu","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0855","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1745-7270.2007.00344.x","article-title":"Cell transformation and proteome alteration in QSG7701 cells transfected with hepatitis C virus non-structural protein 3","volume":"39","author":"He","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.coviro.2016.07.009_bib0860","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1099\/0022-1317-82-9-2235","article-title":"p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3","volume":"82","author":"Kwun","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0865","doi-asserted-by":"crossref","first-page":"30711","DOI":"10.1074\/jbc.M209623200","article-title":"1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2","volume":"278","author":"Park","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.07.009_bib0870","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2016.07.009_bib0875","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v10.i15.2223","article-title":"HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding","volume":"10","author":"Gong","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0880","doi-asserted-by":"crossref","first-page":"18159","DOI":"10.1073\/pnas.0505605102","article-title":"Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase","volume":"102","author":"Munakata","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib0885","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.07.009_bib0890","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.07.009_bib0895","doi-asserted-by":"crossref","first-page":"e27740","DOI":"10.1371\/journal.pone.0027740","article-title":"Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation","volume":"6","author":"Jung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.07.009_bib0900","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1743-422X-10-98","article-title":"The effects of hepatitis C virus core protein on the expression of miR-122 in vitro","volume":"10","author":"Li","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2016.07.009_bib0905","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2015.02.025","article-title":"Hepatitis C virus RNA functionally sequesters miR-122","volume":"160","author":"Luna","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2016.07.009_bib0910","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0915","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib0920","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib0925","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2334-5-95","article-title":"Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection","volume":"5","author":"Bolukbas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib0930","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib0935","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.coviro.2016.07.009_bib0940","first-page":"3335","article-title":"Integrated hepatitis B virus X and 3\u2032 truncated preS\/S sequences derived from human hepatomas encode functionally active transactivators","volume":"9","author":"Schluter","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2016.07.009_bib0945","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3748\/wjg.v22.i6.1943","article-title":"Hepatocellular carcinoma and hepatitis B surface protein","volume":"22","author":"Li","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0950","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2180-11-48","article-title":"Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH","volume":"11","author":"Qadri","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0955","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0960","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/JCM.41.12.5598-5603.2003","article-title":"Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma","volume":"41","author":"Hwang","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0965","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.3748\/wjg.v20.i33.11630","article-title":"Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis","volume":"20","author":"Tarocchi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0970","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1128\/JVI.00172-07","article-title":"Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib0975","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1073\/pnas.94.26.14707","article-title":"Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis","volume":"94","author":"Elmore","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib0980","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","article-title":"Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma","volume":"30","author":"Tian","year":"2015","journal-title":"Virol Sin"},{"key":"10.1016\/j.coviro.2016.07.009_bib0985","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","article-title":"Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers","volume":"22","author":"Ferber","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2016.07.009_bib0990","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(82)90156-8","article-title":"Influence of delta infection on severity of hepatitis B","volume":"2","author":"Smedile","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.07.009_bib0995","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/JVI.68.2.1052-1058.1994","article-title":"Expression of the hepatitis delta virus large and small antigens in transgenic mice","volume":"68","author":"Guilhot","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1000","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(88)80457-4","article-title":"Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease","volume":"6","author":"Negro","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4254\/wjh.v7.i5.777","article-title":"Hepatitis D and hepatocellular carcinoma","volume":"7","author":"Abbas","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.gastro.2011.03.045","article-title":"A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma","volume":"141","author":"Abu Dayyeh","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.07.009_bib1045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.07.009_bib1050","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00262-009-0660-4","article-title":"\u2212509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection","volume":"58","author":"Qi","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.coviro.2016.07.009_bib1055","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2169\/internalmedicine.49.3268","article-title":"The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma","volume":"49","author":"Okamoto","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.2483","article-title":"Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma","volume":"45","author":"Jiang","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1075","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.24799","article-title":"Genetic variants in human leukocyte antigen\/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development","volume":"55","author":"Hu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2012.03.004","article-title":"Why men are at higher risk for hepatocellular carcinoma?","volume":"57","author":"Keng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ajg.2014.214","article-title":"Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans","volume":"109","author":"El-Serag","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2015.06.004","article-title":"Determinants of hepatitis B and delta virus host tropism","volume":"13","author":"Winer","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1095","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.12157","article-title":"In vivo models of hepatitis B and C virus infection","author":"Winer","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coviro.2016.07.009_bib1100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)64980-2","article-title":"Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B","volume":"156","author":"Chisari","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.07.009_bib1110","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.07.009_bib1120","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2016.07.009_bib1125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajpath.2013.09.008","article-title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice","volume":"184","author":"Gutti","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1140","doi-asserted-by":"crossref","first-page":"e0119820","DOI":"10.1371\/journal.pone.0119820","article-title":"A novel mouse model for stable engraftment of a human immune system and human hepatocytes","volume":"10","author":"Strick-Marchand","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.07.009_bib1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.04.022","article-title":"Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells","author":"Billerbeck","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1155","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1160","doi-asserted-by":"crossref","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.07.009_bib1165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.07.009_bib1170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.07.009_bib1180","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/emi.2014.19","article-title":"Natural reservoirs for homologs of hepatitis C virus","volume":"3","author":"Pfaender","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1185","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.75.9.4533","article-title":"A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks","volume":"75","author":"Summers","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib1190","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1073\/pnas.81.7.2208","article-title":"Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck","volume":"81","author":"Ponzetto","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib1195","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/hupa.2001.28228","article-title":"Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C","volume":"32","author":"Fontaine","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1205","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1572-0241.2007.01751.x","article-title":"Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management","volume":"103","author":"Fung","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2013.06.008","article-title":"Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study","volume":"67","author":"Lunel-Fabiani","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.coviro.2016.07.009_bib1215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1478-3231.2006.01430.x","article-title":"Progression to cirrhosis in hepatitis C patients: an age-dependent process","volume":"27","author":"Pradat","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.coviro.2016.07.009_bib1220","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1225","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/155.5.931","article-title":"Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B","volume":"155","author":"Fattovich","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.07.009_bib1230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2016.07.009_bib1235","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2893.2010.01353.x","article-title":"Natural history and treatment of chronic delta hepatitis","volume":"17","author":"Yurdaydin","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2016.07.009_bib1245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jvh.12043","article-title":"Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update","volume":"20","author":"Kew","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2016.07.009_bib1250","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2010.06.008","article-title":"Outcome of chronic delta hepatitis in Italy: a long-term cohort study","volume":"53","author":"Niro","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/ilar.42.2.117","article-title":"The chimpanzee model of hepatitis C virus infections","volume":"42","author":"Lanford","year":"2001","journal-title":"ILAR J"},{"key":"10.1016\/j.coviro.2016.07.009_bib1260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hep.27773","article-title":"Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice","volume":"62","author":"Scull","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1265","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/cr.2014.116","article-title":"Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2016.07.009_bib1270","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.07.009_bib1275","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.07.009_bib1280","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2008.07.020","article-title":"Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo","volume":"49","author":"Griffin","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1285","first-page":"5","article-title":"The chimpanzee model for hepatitis B virus infection","author":"Wieland","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2016.07.009_bib1290","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1099\/0022-1317-83-7-1645","article-title":"Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus","volume":"83","author":"Gheit","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01261404","article-title":"Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus","volume":"122","author":"Yan","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1300","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1128\/JVI.62.11.4144-4152.1988","article-title":"Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome","volume":"62","author":"Farza","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cmi.2013.66","article-title":"HBV life cycle is restricted in mouse hepatocytes expressing human NTCP","volume":"11","author":"Li","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1310","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1073\/pnas.95.10.5757","article-title":"Isolation of a hepadnavirus from the woolly monkey, a New World primate","volume":"95","author":"Lanford","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.07.009_bib1315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(04)63001-6","article-title":"Duck hepatitis B virus: an invaluable model system for HBV infection","volume":"63","author":"Schultz","year":"2004","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.coviro.2016.07.009_bib1320","first-page":"308","article-title":"Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage","volume":"122","author":"Fields","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1325","first-page":"315","article-title":"Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee","volume":"122","author":"Govindarajan","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2016.07.009_bib1330","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1128\/JVI.69.8.4880-4887.1995","article-title":"Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle","volume":"69","author":"Polo","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.07.009_sbref1335","doi-asserted-by":"crossref","first-page":"e1004840","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.07.009_bib1340","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/hep.21112","article-title":"Characterization of a hepatitis B and hepatitis delta virus receptor binding site","volume":"43","author":"Engelke","year":"2006","journal-title":"Hepatology"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571630092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571630092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T18:05:48Z","timestamp":1600970748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962571630092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":134,"alternative-id":["S187962571630092X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.07.009","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocarcinogenesis associated with hepatitis B, delta and C viruses","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}